{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:16:39Z","timestamp":1772856999980,"version":"3.50.1"},"reference-count":3,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,4,15]]},"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1136\/bcr-2018-228968","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T11:38:42Z","timestamp":1556624322000},"page":"e228968","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-238X","authenticated-orcid":false,"given":"Leonor Vasconcelos","family":"Matos","sequence":"first","affiliation":[{"name":"Oncology, Hospital Sao Francisco Xavier, Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5649-4271","authenticated-orcid":false,"given":"Ana","family":"Pissarra","sequence":"additional","affiliation":[{"name":"Medical Oncology, Hospital de S\u00e3o Francisco Xavier, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Malheiro","sequence":"additional","affiliation":[{"name":"Medical Oncology, Hospital de S\u00e3o Francisco Xavier, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Neto","family":"Pl\u00e1cido","sequence":"additional","affiliation":[{"name":"Medical Oncology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"2025082708474182000_12.4.e228968.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04226.x"},{"key":"2025082708474182000_12.4.e228968.2","unstructured":"European Medicines Agency, European Public Assessment Report, Erbitux product information. First Published 14\/07\/2009, Last Updated 19\/07\/2017. https:\/\/www.ema.europa.eu\/documents\/productinformation\/erbitux-epar-product-information_en.pdf"},{"key":"2025082708474182000_12.4.e228968.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.04.026"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-228968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:47:50Z","timestamp":1756309670000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-228968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":3,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,30]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1136\/bcr-2018-228968"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-228968","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}